journal article·2018-01-31

Antimicrobial Properties and Osteogenicity of Vancomycin-Loaded Synthetic Scaffolds Obtained by Supercritical Foaming

Carlos A. García-González, Joana Barros, Ana Rey-Rico, Pablo Redondo, José L. Gómez-Amoza, Angel Concheiro, Carmen Alvarez-Lorenzo, Fernando J. Monteiro

Publisher page

Abstract

Advanced porous synthetic scaffolds are particularly suitable for regeneration of damaged tissues, but there is the risk of infections due to the colonization of microorganisms, forming biofilms. Supercritical foaming is an attractive processing method to prepare bone scaffolds, regulating simultaneously the porosity and loading of bioactive compounds without loss of activity. In this work, scaffolds made of poly-ε-caprolactone (50 kDa), containing chitosan and an antimicrobial agent (vancomycin), were processed by supercritical CO 2 foaming for bone regeneration purposes. The obtained scaffolds showed a suitable combination of morphological (porosity, pore size distribution, and interconnectivity), time-dependent in vitro vancomycin release behavior and biological properties (cell viability and proliferation, osteodifferentiation, and tissue-scaffold integration). The scaffolds sustained vancomycin release for more than 2 weeks. Finally, the antimicrobial activity of the scaffolds was tested against Gram-positive ( Staphylococcus aureus ) and Gram-negative ( Escherichia coli ) bacteria after 24 h of incubation with full growth inhibition for S. aureus .
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Orthopaedic implants and arthroplasty · Polymer Foaming and Composites · Orthopedic Infections and Treatments

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Departamento de Farmacología, Farmacia y Tecnología Farmacéutica, R+D Pharma Group (GI-1645), Facultad de Farmacia and Health Research Institute of Santiago de Compostela (IDIS), Universidade de Santiago de Compostela, E-15782 Santiago de Compostela, Spain

FEUP-Faculdade de Engenharia, Universidade do Porto, I3S-Instituto de Investigação e Inovação em Saúde, and INEB-Instituto de Engenharia Biomédica, Porto 4200-135, Portugal

Center of Experimental Orthopaedics, Saarland University Medical Center, Homburg 66421, Germany

Funding

European Commission · Ministerio de Econom?a y Competitividad · Conseller?a de Cultura, Educaci?n e Ordenaci?n Universitaria, Xunta de Galicia · Banco Santander SA

References (55)

Show source-provided references
1. 10.1016/j.biomaterials.2013.01.07410.1016/j.biomaterials.2013.01.074 ↗
2. 10.1016/j.colsurfb.2015.04.03410.1016/j.colsurfb.2015.04.034 ↗
3. 10.1016/j.biomaterials.2010.05.00510.1016/j.biomaterials.2010.05.005 ↗
4. 10.1186/s13018-015-0294-510.1186/s13018-015-0294-5 ↗
5. Zilberman M. · 2010 · 29910.1007/978-3-642-00477-3_11 ↗
6. 10.1039/c4ra17244b10.1039/c4ra17244b ↗
7. 10.1016/j.jconrel.2008.05.02010.1016/j.jconrel.2008.05.020 ↗
8. 10.3410/m4-410.3410/m4-4 ↗
9. 10.1007/bf0196756310.1007/bf01967563 ↗
10. 10.2147/ijn.s7867510.2147/ijn.s78675 ↗
11. 10.1128/jb.01383-1310.1128/jb.01383-13 ↗
12. 10.1128/aac.03502-1410.1128/aac.03502-14 ↗
13. 10.1097/00003086-199612000-0002710.1097/00003086-199612000-00027 ↗
14. 10.1517/14740338.2011.58983310.1517/14740338.2011.589833 ↗
15. 10.14444/401210.14444/4012 ↗
16. 10.1007/bf0018186110.1007/bf00181861 ↗
17. 10.1016/s0022-3549(15)00175-610.1016/s0022-3549(15)00175-6 ↗
18. 10.1021/bc500592210.1021/bc5005922 ↗
19. 10.1016/j.jcou.2017.01.02810.1016/j.jcou.2017.01.028 ↗
20. 10.1016/j.carbpol.2016.01.05110.1016/j.carbpol.2016.01.051 ↗
21. 10.1039/c6ra09369h10.1039/c6ra09369h ↗
22. 10.1016/j.ajps.2016.07.00110.1016/j.ajps.2016.07.001 ↗
23. 10.1016/j.bjp.2015.09.01010.1016/j.bjp.2015.09.010 ↗
24. 10.1016/j.msec.2012.02.02110.1016/j.msec.2012.02.021 ↗
25. 10.1088/1758-5090/aa78c510.1088/1758-5090/aa78c5 ↗
26. 10.1016/j.apsusc.2006.02.00910.1016/j.apsusc.2006.02.009 ↗
27. 10.1002/(SICI)1097-4628(19980118)67:3<405::AID-APP3>3.0.CO;2-Q10.1002/(SICI)1097-4628(19980118)67:3<405::AID-APP3>3.0.CO;2-Q ↗
28. 10.1016/j.actbio.2015.08.04610.1016/j.actbio.2015.08.046 ↗
29. Freshney R. I. · 2000
30. 10.22203/ecm.v021a2410.22203/ecm.v021a24 ↗
31. 10.1016/j.ijpharm.2017.05.03810.1016/j.ijpharm.2017.05.038 ↗
32. ICCVAM.ICCVAM-Recommended Test Method Protocol: Hen’s Egg Test—Chorioallantoic Membrane (HET-CAM) Test Method.http://iccvam.niehs.nih.gov/methods/ocutox/MildMod-TMER.htm(accessed 23/01/ 2017) .
33. 10.1016/j.msec.2015.08.02410.1016/j.msec.2015.08.024 ↗
34. 10.1021/ie402256a10.1021/ie402256a ↗
35. 10.1177/0021955x0707959110.1177/0021955x07079591 ↗
36. 10.1016/j.jcou.2017.12.01210.1016/j.jcou.2017.12.012 ↗
37. 10.1093/jac/dks51010.1093/jac/dks510 ↗
38. Serri A. · Acta Pol. Pharm. · 2017 · 74 · 73
39. 10.4149/bll_2014_15410.4149/bll_2014_154 ↗
40. 10.2147/ijn.s1721810.2147/ijn.s17218 ↗
41. 10.1016/j.ijpharm.2013.08.04210.1016/j.ijpharm.2013.08.042 ↗
42. 10.1016/j.biomaterials.2006.08.01310.1016/j.biomaterials.2006.08.013 ↗
43. 10.1039/c6tb01623e10.1039/c6tb01623e ↗
44. 10.1021/ie060055v10.1021/ie060055v ↗
45. Peppas N. A. · Pharm. Acta Helv. · 1985 · 60 · 110
46. 10.3390/ijms15081384910.3390/ijms150813849 ↗
47. 10.1038/jid.2009.9510.1038/jid.2009.95 ↗
48. 10.1128/aac.01628-0810.1128/aac.01628-08 ↗
49. 10.1016/j.carbpol.2015.07.07210.1016/j.carbpol.2015.07.072 ↗
50. 10.1097/blo.0b013e31811ff86610.1097/blo.0b013e31811ff866 ↗
51. 10.1016/j.msec.2016.05.03310.1016/j.msec.2016.05.033 ↗
52. 10.1007/s10856-016-5671-z10.1007/s10856-016-5671-z ↗
53. 10.1002/adhm.20170001410.1002/adhm.201700014 ↗
54. 10.1038/srep3216810.1038/srep32168 ↗
55. 10.1161/res.000000000000005410.1161/res.0000000000000054 ↗